Physician

Gwen D Abeles, M.D.

According to 2025 Medicare claims, Gwen Abeles, M.D. (NPI: 1447222625) practices dermatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is ENHANCE DERMATOLOGY, PC (NPI: 1720236110; TIN: 263092013) and primary practice location at 07645-0361.

Abeles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,164 traditional Medicare patients, billed 13,646 HCPCS/CPT codes, and received $1,076,850 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 942 prescription claims across 488 beneficiaries totaling $26,299 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 67 records totaling $1,894. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $241,663 to $1,076,850. In contrast, Part D prescription costs have declined steadily, from $62,702 to $26,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	600	5,362	$241,663
2016	701	5,652	$248,800
2017	777	6,309	$262,712
2018	830	7,196	$278,976
2019	910	9,995	$597,775
2020	732	8,359	$596,691
2021	900	10,496	$861,865
2022	1,024	12,459	$1,011,033
2023	1,109	12,720	$1,022,537
2024	1,164	13,646	$1,076,850

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	411	$62,702
2016	198	347	$38,187
2017	249	448	$46,053
2018	249	447	$44,794
2019	260	470	$53,513
2020	217	398	$37,806
2021	332	622	$29,484
2022	351	686	$25,572
2023	355	682	$28,177
2024	488	942	$26,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	525	717	$103
17110	Destruction of skin growth, 1-14 growths	273	373	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	816	1,646	$74
17000	Destruction of precancer skin growth, 1 growth	617	1,122	$46
17003	Destruction of precancer skin growth, 2-14 growths	486	3,930	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	85	2,522	$5,487
Fluocinonide	Fluocinonide	72	2,089	$3,933
Tacrolimus	Tacrolimus	25	904	$3,874
Mupirocin	Mupirocin	229	4,185	$1,599
Triamcinolone Acetonide	Triamcinolone Acetonide	137	3,454	$823

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	67	$1,894	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gwen D. Abeles, M.D.?

Tedicare shows public-source Medicare data for Gwen D. Abeles, M.D. (NPI 1447222625), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gwen D. Abeles, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gwen D. Abeles, M.D.?

Gwen D. Abeles, M.D. is linked to ENHANCE DERMATOLOGY, PC (billing NPI 1720236110) in the available physician profile data.

Does Gwen D. Abeles, M.D. have Open Payments data?

Gwen D. Abeles, M.D. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.